Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab
Background: Monocyte to high-density lipoprotein cholesterol ratio (MHR) is a novel inflammatory biomarker which has been associated with cardiovascular diseases. Objective: To study MHR in patients with psoriasis treated with biological agents. Methods: Between April 2019 and August 2022, MHR was r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Permanyer,
2023-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|